Practice Focus

Help or Hoopla?: Surgical robots can benefit otolaryngology

The large, roadside billboards advertised robotic surgery in bright, bold colors, something that struck David Eibling, MD, professor of otolaryngology at the University of Pittsburgh, as “fundamentally wrong.” Hospitals and physicians “should not be offering robotic surgery as a draw for patients,” said Dr. Eibling, who noticed the billboards while traveling through Florida earlier this year, “but rather as a potential tool to benefit the care of the patient.”

An Unofficial First-Line Treatment: Propranolol gains widespread use for infantile hemangiomas

Since the first report in 2008 of the effectiveness of propranolol to treat infantile hemangiomas, its use has grown among physicians who treat these tumors, which arise in 5 to 10 percent of infants. Among these infants, approximately 10 percent will require treatment to correct functional impairment or prevent lasting cosmetic deformity caused by the hemangioma.

A Prevalent Problem: Studies report sleep deprivation in colleagues, patients

Among the issues highlighted here last month at SLEEP 2011, the 25th Annual Meeting of the Associated Professional Sleep Societies, was the effect of inadequate sleep on both the health of the individual and on society at large. Two studies presented at the meeting, for example, looked at the effects of inadequate sleep on health care providers and the risks posed to their health and the health of their patients. Another study put into context just how underreported inadequate sleep and sleep disorders are and elaborated on the challenge this poses to otolaryngologists and others who are on the frontlines managing these disorders.

Lecturer Warns Against Overuse of CRT: Says many early-stage laryngeal cancer patients overtreated

Chemoradiation therapy (CRT) for head and neck cancer is overused at some centers in patients with early-stage laryngeal cancer, and more care should be taken not to overtreat patients with therapy that can have toxic effects, said invited lecturer Jonas Johnson, MD, at the Annual Meeting of the Triological Society, held here on April 29 as part of the Combined Otolaryngology Spring Meetings.

New Tool Could Aid Decisions on Elective Neck Dissection: Fast polymerase chain reaction detects sentinel lymph node positivity

Quantitative real-time polymerase chain reaction (Q-PCR) can be a valuable tool in the operating room to determine whether head and neck cancer patients should go on to elective neck dissection, researchers said here on April 29 at the Annual Meeting of the Triological Society, held as part of the Combined Otolaryngology Spring Meetings.